281-296-7300

  • Awards
  • Careers
logo
  • About
    • About VGXI
    • Leadership
    • VGXI Mission
    • Awards
    • Careers
  • Services
    • Manufacturing Services
    • cGMP Plasmid
    • HD Plasmid
    • Pre-Clinical Plasmid
    • Additional Services
  • VGXI Process
    • VGXI Manufacturing Process
    • Analytical Testing
    • Quality Systems
  • Resource Center
    • News
    • Events
    • FAQs
    • Whitepapers
    • Posters & Presentations
  • Contact Us
  • Awards
  • Careers

Recent News

VGXI Celebrates the Grand Opening for its New Headquarters and Manufacturing Facility

October 10, 2022
With original operations based in The Woodlands, TX, industry recognized plasmid DNA contract manufacturer VGXI, Inc. celebrated the official Grand Opening of its new headquarters and expanded manufacturing facility in Conroe, TX. VGXI, Inc., a specialized contract developer and manufacturer (CDMO) of nucleic acid biopharmaceuticals including gene therapies, DNA vaccines, and RNA… Read More »
  • « Previous
  • 1
  • 2

VGXI, Inc. Names James Smith as New Chief Accounting Officer

April 27, 2023
Industry-recognized plasmid DNA contract manufacturer VGXI, Inc. expands its leadership team with the addition of James Smith as Chief Accounting Officer.   VGXI Inc., a leading contract development and manufacturing organization (CDMO) for plasmid DNA, is pleased to announce the appointment of Mr. James Smith as its new Chief Accounting Officer (CAO)…. Read More »

An Introduction to DNA and Vaccines

August 25, 2022
Vaccines are one of humanity’s most important inventions as they help protect public health and save millions of lives every year. By stimulating the body’s immune system to elicit an immune response, vaccines have protected people from deadly diseases such as smallpox, rinderpest, and malaria, among others. Traditionally, vaccines are made from… Read More »

VGXI Announces Grand Opening Celebration for New Headquarters and Manufacturing Facility

August 17, 2022
Specialized plasmid DNA contract manufacturer VGXI, Inc. announces date for the Grand Opening celebration of its new headquarters and expanded manufacturing facility in Conroe, TX. VGXI, Inc., an industry-leading contract developer and manufacturer (CDMO) of nucleic acid biopharmaceuticals including gene therapies, DNA vaccines, and RNA medicines, announces the official Grand Opening celebration… Read More »

VGXI Celebrates First Look Event at New Manufacturing Facility

April 18, 2022
VGXI opened the doors of its new headquarters and manufacturing facility on 09Apr22 to provide friends and employee families a first look inside and outside the new site! As production is nearing completion, the event was an opportunity for employees and their families to tour the production suites, labs, and office spaces… Read More »

VGXI Official COVID-19 Statement

March 31, 2022
To our Valued Clients and Business Partners, VGXI’s top priority is to continue delivering the highest quality DNA products and services while ensuring the security and safety of our team. VGXI is actively monitoring the evolving situation and will continue to provide updates as new information becomes available. Manufacturing activities have been… Read More »

VGXI Partner IMM Announces $12M NIH Grant to Support Phase 1 Clinical Trial of a DNA Vaccine for the Prevention of Alzheimer’s Disease

March 30, 2022
Texas-based CDMO VGXI, Inc. is excited to announce that its partner, The Institute for Molecular Medicine, has recently been awarded a $12 million NIA grant to support clinical testing of a novel DNA vaccine manufactured by VGXI for the prevention of Alzheimer’s Disease. The Woodlands, TX – VGXI, Inc., an industry recognized… Read More »

VGXI New Manufacturing Facility Achieves Construction Milestones In Advance of 2022 Operational Date

October 4, 2021
Specialized GMP contract manufacturer VGXI, Inc. announced multiple construction milestones have been reached for its new headquarters and expanded manufacturing facility in Conroe, TX. The Woodlands, TX – VGXI, Inc., an industry leading contract developer and manufacturer (CDMO) for nucleic acid biopharmaceuticals including DNA vaccines and gene therapies, announced that its new… Read More »

VGXI, Inc. Partners with Rare Trait Hope Fund in Support of Gene Therapy for Rare Disease, AGU

August 10, 2021
Industry leading plasmid DNA Manufacturer VGXI, Inc. partners with Rare Trait Hope Fund in support of a gene therapy for the rare genetic disease, Aspartylglucosaminuria (AGU). The Woodlands, TX – Contract developer and manufacturer VGXI, Inc., which specializes in production of nucleic acid-based biopharmaceuticals for DNA vaccines and gene therapy applications, announced… Read More »

VGXI Celebrates Topping Out for New Headquarters and Manufacturing Facility in Conroe, TX

April 20, 2021
Texas-based plasmid DNA Manufacturer VGXI, Inc. Celebrates the Topping Out for its New Headquarters and Expanded Manufacturing Facility. The Woodlands, TX – VGXI, Inc., a highly specialized contract developer and manufacturer for DNA-based biopharmaceuticals, celebrated a significant milestone for its new headquarters and manufacturing facility with a topping out ceremony on Monday,… Read More »

VGXI and Geneos Therapeutics Expand Partnership for Personalized Cancer Immunotherapies

March 16, 2021
Texas-based GMP Plasmid CDMO VGXI, Inc. and Geneos Therapeutics, Inc. Expand their Clinical Manufacturing Supply Agreement in Support of Geneos’ Ongoing GT-30 Phase Ib/IIa Clinical Trial for advanced hepatocellular carcinoma (HCC). The Woodlands, TX – VGXI, Inc., an industry leading manufacturer for pre-clinical through cGMP clinical plasmid DNA, announced that its partner… Read More »

VGXI Official Update Following Winter Storm Uri

February 23, 2021
To our Valued Clients and Business Partners, Thank you for everyone’s concern regarding the severe winter storm conditions that swept through Texas during the week of 15Feb21. The VGXI offices remained closed for the week to ensure the safety of all our team members as they faced challenges from icy road conditions,… Read More »

VGXI Breaks Ground for New Manufacturing Facility in Conroe, TX

November 10, 2020
Plasmid DNA Manufacturer VGXI, Inc. Breaks Ground for New Conroe-based Manufacturing Facility. The Woodlands, TX – VGXI, a highly regarded CDMO supporting the gene therapy and DNA vaccine industries, held a groundbreaking ceremony on November 10, 2020 for its new greenfield manufacturing facility. The milestone event was hosted by VGXI in accordance… Read More »
  • 1
  • 2
  • 3
  • …
  • 18
  • Next »

Archives

  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • About
  • Services
  • VGXI Process
  • Contact Us
  • Careers
  • Awards
  • Resource Center

Sign Up For Our Newsletter!

Please enter your name.
Please enter a valid email address.
Sign Up

Thanks for subscribing! Please check your email for further instructions.

Something went wrong. Please check your entries and try again.
logo white

Deison Technology Park (Headquarters)
10130 Deison Park Blvd.
Conroe, Texas 77303, USA

The Woodlands
2700 Research Forest Drive, Suite 180
The Woodlands, Texas 77381, USA

Teko Font

© 2023 VGXI, Inc. All Rights Reserved.Terms | Privacy Policy